Editorial: Aspiration Therapy for Weight Loss: Is the Squeeze worth the Juice

Vivek Kumbhari, Patrick I. Okolo

Research output: Contribution to journalReview article

Abstract

There is a desperate need for a technically simple, reversible, clinically effective, and safe approach to facilitate weight loss and improvement in metabolic comorbidities in obese patients. This has led to significant investment into the development of endoscopic bariatric therapies. In this issue of the American Journal of Gastroenterology, the first randomized controlled trial assessing aspiration therapy using an endoscopically placed gastrostomy tube is reported with promising results. Aspiration therapy is the first endoscopic therapy to be approved in the United States for use in morbidly obese patients and may be an alternative to those not wishing to undergo bariatric surgery.

Original languageEnglish (US)
Pages (from-to)458-459
Number of pages2
JournalAmerican Journal of Gastroenterology
Volume112
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Weight Loss
Bariatrics
Gastrostomy
Bariatric Surgery
Gastroenterology
Therapeutics
Comorbidity
Randomized Controlled Trials

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Editorial : Aspiration Therapy for Weight Loss: Is the Squeeze worth the Juice. / Kumbhari, Vivek; Okolo, Patrick I.

In: American Journal of Gastroenterology, Vol. 112, No. 3, 01.03.2017, p. 458-459.

Research output: Contribution to journalReview article

@article{7fb2af97d47d4771b62580eed27a12a2,
title = "Editorial: Aspiration Therapy for Weight Loss: Is the Squeeze worth the Juice",
abstract = "There is a desperate need for a technically simple, reversible, clinically effective, and safe approach to facilitate weight loss and improvement in metabolic comorbidities in obese patients. This has led to significant investment into the development of endoscopic bariatric therapies. In this issue of the American Journal of Gastroenterology, the first randomized controlled trial assessing aspiration therapy using an endoscopically placed gastrostomy tube is reported with promising results. Aspiration therapy is the first endoscopic therapy to be approved in the United States for use in morbidly obese patients and may be an alternative to those not wishing to undergo bariatric surgery.",
author = "Vivek Kumbhari and Okolo, {Patrick I.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1038/ajg.2017.2",
language = "English (US)",
volume = "112",
pages = "458--459",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Editorial

T2 - Aspiration Therapy for Weight Loss: Is the Squeeze worth the Juice

AU - Kumbhari, Vivek

AU - Okolo, Patrick I.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - There is a desperate need for a technically simple, reversible, clinically effective, and safe approach to facilitate weight loss and improvement in metabolic comorbidities in obese patients. This has led to significant investment into the development of endoscopic bariatric therapies. In this issue of the American Journal of Gastroenterology, the first randomized controlled trial assessing aspiration therapy using an endoscopically placed gastrostomy tube is reported with promising results. Aspiration therapy is the first endoscopic therapy to be approved in the United States for use in morbidly obese patients and may be an alternative to those not wishing to undergo bariatric surgery.

AB - There is a desperate need for a technically simple, reversible, clinically effective, and safe approach to facilitate weight loss and improvement in metabolic comorbidities in obese patients. This has led to significant investment into the development of endoscopic bariatric therapies. In this issue of the American Journal of Gastroenterology, the first randomized controlled trial assessing aspiration therapy using an endoscopically placed gastrostomy tube is reported with promising results. Aspiration therapy is the first endoscopic therapy to be approved in the United States for use in morbidly obese patients and may be an alternative to those not wishing to undergo bariatric surgery.

UR - http://www.scopus.com/inward/record.url?scp=85014696164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014696164&partnerID=8YFLogxK

U2 - 10.1038/ajg.2017.2

DO - 10.1038/ajg.2017.2

M3 - Review article

C2 - 28270668

AN - SCOPUS:85014696164

VL - 112

SP - 458

EP - 459

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 3

ER -